Louisiana Board of Pharmacy - State of Louisiana

Print RSS Share This Site
photo-pharmacist State of Louisiana

Legislative Proposals



2018-K ~ Amends the PMP Law to grant access to state epidemiologists with Dept. of Health.
               02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
               02-21-2018 - Draft #3 approved for filing by the Board.
               02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 232 (SB 109).


2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
               02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-21-2018 - Draft #1 approved for filing by the Board.
               02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 31 (SB 131).


2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
               02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
               02-21-2018 - Draft #2 approved for filing by the Board.
               02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 146 (SB 110).


2018-G ~ Amends the Prescription Monitoring Program (PMP) Law to change the reporting frequency for dispensers of controlled substances and drugs of concern.
               02-07-2018 - Committee voted to defer action on Draft #1 until a later date.


2018-F ~ Amends the Prescription Monitoring Program (PMP) Law to authorize designated representatives of the Medicaid program to access audit trail information for providers caring for Medicaid recipients.
               02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
               02-21-2018 - Board declined to approve Draft #3 for filing by the Board.              


2018-E ~ Amends the Controlled Substances Law to permit the partial filling of prescriptions for all medications listed in Schedule II, consistent with federal legislation adopted in 2016.
               02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-21-2018 - Draft #1 approved for filing by the Board.
               02-27-2018 - Incorporated in SB 134; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 32 (SB 134).


2018-D ~ Amends the Pharmacy Practice Act to allow the Board to waive the license renewal fee for spouses of pharmacists or technicians serving in active duty military.
               11-15-2017 - Draft #1 approved for filing by the Board.
               02-26-2018 - Incorporated in HB 150: prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 63 (HB 150).


2018-C ~ Amends the statutory definition of "approved college of pharmacy" in the Pharmacy Practice Act to remove a specifically titled reference book of foreign pharmacy schools.
               02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-21-2018 - Draft #1 approved for filing by the Board.
               02-26-2018 - Incorporated in HB 151; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 64 (HB 151).


2018-B ~ Amends the Controlled Substances Law to define 'third-party logistics provider', identify such an entity as one of the entities requiring a Controlled Dangerous Substance (CDS) license to transact business with controlled substances, and to set the fee for CDS licenss issued to such entities.
               09-28-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
               11-15-2017 - Draft #1 approved for filing by the Board.
               01-31-2018 - Incorporated in HB 45; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 186 (HB 45).


2018-A ~ Amends the Controlled Substances Law to add additional substances to Schedule I and removes a substance from Schedule II, consistent with DEA scheduling actions since the last state legislative session.
               02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-21-2018 - Draft #1 approved for filing by the Board.
               01-31-2018 - Incorporated in HB 153; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 119 (HB 153).


2017-E ~ Amends the Insurance Law to define 'specialty drugs' and prohibit any entity from establishing alternative definitions for this term or adding any other requirements that will limit patient access to prescription drugs.  The draft legislation was incorporated into the Board's response to SCR 87 of the 2016 Legislature, which requested the Board to study the issue of specialty drugs and specialty pharmacies and make recommendations to the legislature.
               01-12-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
               01-25-2017 - Approved for filing by Board.
               01-30-2017 - Board's reply to SCR 87 (2016) submitted to Louisiana Legislature.


2017-D ~ Amends the Prescription Monitoring Program (PMP) Law to establish audit trail information and restrict its disclosure, adds additional persons authorized to access PMP information, and updates the immunity provisions for the board and advisory council.
               01-12-2017 - Committee considered Draft #2, requested one amendment, then voted to recommend the approval of Draft #3 to the Board.
               01-25-2017 - Approved for filing by Board.
               03-30-2017 - Incorporated in SB 96; prefiled for 2017 Regular Session.
               06-14-2017 - Effective date of Act 241 (SB 96).


2017-C ~ Seeks to license and regulate those activities of pharmacy benefit managers construed to be within the practice of pharmacy..
               01-12-2017 - Committee considered Draft #1, requested some amendments, and then deferred further consideration until its next meeting.
               02-09-2017 - Committee voted the recommend the approval of Draft #2.
               03-14-2017 - Board voted to submit Draft #2 requesting the drafting of legislation.
               03-15-2017 - Draft #2 submitted to House of Representatives Health & Welfare Committee.


2017-B ~ Amends the Controlled Substances Law to add third party logistics (3PL) companies as an entity required to obtain a Controlled Dangerous Substance (CDS) license in order to handle controlled substances in Louisiana, and sets the annual license fee.
               01-12-2017 - Committee voted to recommend the approval of Draft #1 to the Board.
               01-25-2017 - Approved for filing by Board.
               03-30-2017 - Unable to secure legislative sponsor prior to session (limitation on number of bills).


2017-A ~ Amends the Controlled Substances Law to add U-47700, furanylfentanyl, acrylfentanyl, and etizolam to Schedule I, thiafentanil to Schedule II, and brivaracetam to Schedule V.
               01-12-2017 - Committee voted to recommend the approval of Draft #2 to the Board.
               01-25-2017 - Approved for filing by Board.
               03-29-2017 - Incorporated in HB 225; prefiled for 2017 Regular Session.
               08-01-2017 - Effective date of Act 100 (HB 225).


2016-C ~ Amends the Pharmacy Practice Act to add a new fee applicable only to applications for a marijuana pharmacy permit.
               01-19-2016 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-24-2016 - Approved for filing by the Board.
               03-03-2016 - Incorporated in HB 446; prefiled for 2016 Regular Session
               05-25-2016 - HB 446 failed to pass Senate floor vote; bill died when session adjourned on 06-06-2016.


2016-B ~ Amends the Prescription Monitoring Program (PMP) Law to allow the Board to develop rules for the retention and archiving of prescription transaction data collected by the program.
               01-19-2016 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-24-2016 - Approved for filing by the Board.
               03-01-2016 - Incorporated in SB 56; prefiled for 2016 Regular Session.
               08-01-2016 - Effective date of Act 189 (SB 56).


2016-A ~ Amends the Controlled Substances Law to remove naloxegol and ioflupane from Schedule II and add eluxadoline to Schedule IV.
               01-19-2016 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-24-2016 - Approved for filing by the Board.
               03-04-2016 - Incorporated in HB 688; prefiled for 2016 Reguar Session.
               08-01-2016 - Effective date of Act 62 (HB 688).


2015-C ~ Amends the Prescription Monitoring Program (PMP) Law to harmonize the restriction on disclosure requirements when sharing program data with other states, to enable the program to share data with more states.
               01-22-2015 - Draft #2 reviwed by Regulation Revision Committee, which voted to recommend its approval to the Board.
               02-25-2015 - Approved for filing by the Board.
               03-31-2015 - Incorporated in HB 304; filed for 2015 Regular Session.
               08-01-2015 - Effective date of Act 22 (HB 304).


2015-B ~ Amends the Controlled Substances Law to change the hydrocodone combination products from Schedule III to Schedule II, and adds suvorexant and tramadol to Schedule IV.
               01-22-2015 - Reviewed by Regulation Revision Committee, which voted to recommend its approval to the Board.
               02-25-2015 - Approved for filing by the Board.
               03-26-2015 - Incorporated in HB 174; filed for 2015 Regular Session.
               06-23-2015 - Effective date of Act 189 (HB 174).


2015-A ~ Amends the Public Records Law to add investigative reports of CDS licensees to the list of records exempted from the disclosure requirements.
               01-22-2015 - Draft #2 reviewed by Regulation Revision Committee, which voted to recommend its approval to the Board.
               02-25-2015 - Approved for filing by the Board.


2014-B ~ Amends the Prescription Monitoring Program Law relative to the frequency of reporting prescription transactions to the program database.
               02-06-2014 - Reviewed by Regulation Revision Committee which voted to recommend approval of Draft #2 to the Board.
               02-12-2014 - Approved for filing by the Board.
               03-10-2014 - Incorporated in SB 556; filed for 2014 Regular Session.
               08-01-2014 - Effective date of Act 472 (SB 556).


2014-A ~ Amends the Louisiana Controlled Substances Law to add new drugs to Schedules II, III, and IV.
               02-06-2014 - Reviewed by Regulation Revision Committee which voted to recommend approval of Draft #1 to the Board.
               02-12-2014 - Approved for filing by the Board.
               02-18-2014 - Incorporated in HB 212; prefiled for 2014 Regular Session.
               08-01-2014 - Effective date of Act 40 (HB 212).